Showing results (31-40 of 190) with videos related to

Sort By:
Pageof 19
Medicine|June 3, 2020
All-cause mortality and the risk of stroke with selective aspiration thrombectomy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A nationwide retrospective cohort studyYing-Chang Tung, Lai-Chu See, Shu-Hao Chang, et al.
Heart Rhythm|May 23, 2021
Tachypacing-induced CREB/CD44 signaling contributes to the suppression of L-type calcium channel expression and the development of atrial remodelingShang-Hung Chang, Yi-Hsin Chan, Wei-Jan Chen, et al.
ESC Heart Failure|July 7, 2020
Sodium glucose cotransporter-2 inhibitor was associated with an improvement in left ventricular systolic function in patients with type 2 diabetes mellitus with impaired left ventricular systolic functionYi-Hsin Chan, Tzyy-Jer Hsu, Chun-Li Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 31, 2023
The Association of Background Medications on Initial eGFR Change and Kidney Outcomes in Diabetic Patients Receiving SGLT2 InhibitorYi-Hsin Chan, Tze-Fan Chao, Shao-Wei Chen, et al.
Internal Medicine Journal|December 2, 2017
Delayed diagnosis of atrial fibrillation after first-ever stroke increases recurrent stroke risk: a 5-year nationwide follow-up studyPing-Song Chou, Bo-Lin Ho, Yi-Hsin Chan, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|July 7, 2022
Association of acute increases in serum creatinine with subsequent outcomes in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitor or dipeptidyl peptidase-4 inhibitorYi-Hsin Chan, Tze-Fan Chao, Shao-Wei Chen, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 2022
New-Onset Atrial Fibrillation in Patients With Type 2 Diabetes Treated With Novel Glucose-Lowering TherapiesFu-Chih Hsiao, Kun-Chi Yen, Tze-Fan Chao, et al.
Journal of Cardiology|July 23, 2013
Prognostic value of global left ventricular strain for conservatively treated patients with symptomatic aortic stenosisHsin-Fu Lee, Lung-An Hsu, Yi-Hsin Chan, et al.
Cardiovascular Diabetology|May 4, 2021
The impact of weight loss related to risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitorYi-Hsin Chan, Shao-Wei Chen, Tze-Fan Chao, et al.
Cardiovascular Diabetology|August 17, 2021
The risk of consequent nephropathy following initial weight loss in diabetic patients treated with sodium glucose cotransporter 2 inhibitorsYi-Hsin Chan, Shao-Wei Chen, Tze-Fan Chao, et al.
Pageof 19